US health regulator extends review of Biogen’s ALS drug
Biogen said it had submitted responses to the FDA's information requests, which the agency said would require additional time for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Tofersen
Promising MND drug helps slow disease progression and benefits patients physically
Patients on the trial reported better patient mobility and lung function after 12 months